ETOPOSIDE (VP16-213) - A PODOPHYLLOTOXIN-DERIVATIVE WITH HIGH ANTI-TUMOR ACTIVITY

被引：21
|
作者：
SCHMOLL, HJ
NIEDERLE, N
ACHTERRATH, W
机构：
[1] HANOVER UNIV MED, DEPT INNERE MED, D-3000 HANOVER, FED REP GER
[2] UNIV ESSEN GESAMTHSCH, INNERE KLIN & POLIKLIN WESTDEUTSCH TUMOR ZENTRUM, D-4300 ESSEN, FED REP GER
[3] BRISTOL MYERS GMBH, KLIN FORSCH ZYTOSTATIKA ABT, NEU ISENBURG, FED REP GER
来源：
KLINISCHE WOCHENSCHRIFT | 1981年 / 59卷 / 21期
关键词：
D O I：
10.1007/BF01721212
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1177 / 1188
页数：12
相关论文
共 50 条
  • [21] EFFECT OF ETOPOSIDE (VP16-213) ON LIPID-PEROXIDATION AND ANTIOXIDANT STATUS IN A HIGH-DOSE RADIOCHEMOTHERAPY REGIMEN
    LADNER, C
    EHNINGER, G
    GEY, KF
    CLEMENS, MR
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1989, 25 (03) : 210 - 212
  • [22] PHASE-II STUDY OF VP16-213 (ETOPOSIDE) IN REFRACTORY METASTATIC BREAST-CARCINOMA
    SCHELL, FC
    YAP, HY
    HORTOBAGYI, GN
    ISSELL, B
    ESPARZA, L
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1982, 7 (2-3) : 223 - 225
  • [23] VINCRISTINE, ADRIAMYCIN, CYCLOPHOSPHAMIDE, AND ETOPOSIDE (VP16-213) IN SMALL-CELL ANAPLASTIC CARCINOMA OF THE LUNG
    VONEYBEN, FE
    ARWIDI, A
    HELLEKANT, C
    JONSSON, K
    LINDAHL, SA
    MATTSSON, W
    TENNVALL, L
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1982, 7 (2-3) : 195 - 197
  • [24] A PHASE-II STUDY OF VP16-213 (ETOPOSIDE) IN REFRACTORY METASTATIC BREAST-CARCINOMA
    SCHELL, FC
    YAP, HY
    BLUMENSCHEIN, GR
    ESPARZA, L
    ISSELL, B
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1982, 7 (2-3) : 243 - 243
  • [25] CHROMATOGRAPHY, ELECTROCHEMISTRY AND MASS-SPECTROMETRY OF THE ANTI-TUMOR AGENT VP-16-213 (ETOPOSIDE) AND METABOLITES IN BIOLOGICAL-FLUIDS
    VANOORT, WJ
    HOLTHUIS, JJM
    [J]. PHARMACEUTISCH WEEKBLAD-SCIENTIFIC EDITION, 1983, 5 (06) : 336 - 336
  • [26] PHARMACOKINETICS OF HIGH-DOSE ETOPOSIDE (VP 16-213)
    HOLTHUIS, JJM
    POSTMUS, PE
    VANOORT, WJ
    HULSHOFF, B
    VERLEUN, H
    SLEIJFER, DT
    MULDER, NH
    [J]. EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1986, 22 (10): : 1149 - 1155
  • [27] DRUG-MONITORING OF ETOPOSIDE (VP16-213) CORRELATION OF PHARMACOKINETIC PARAMETERS TO CLINICAL AND BIOCHEMICAL DATA FROM PATIENTS RECEIVING ETOPOSIDE
    PFLUGER, KH
    SCHMIDT, L
    MERKEL, M
    JUNGCLAS, H
    HAVEMANN, K
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1987, 20 (01) : 59 - 66
  • [28] ETOPOSIDE (VP16-213) AND TENIPOSIDE (VM26) COMPARATIVE INVITRO ACTIVITIES IN HUMAN-TUMORS
    ISSELL, BF
    TIHON, C
    CURRY, ME
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1982, 7 (2-3) : 113 - 115
  • [29] DISSIMILAR EFFECTS ON THYMIDINE INCORPORATION AND DNA-SYNTHESIS OF PODOPHYLLOTOXIN DERIVATIVE VP 16-213
    GRIEDER, A
    MAURER, R
    STAHELIN, H
    [J]. EXPERIENTIA, 1973, 29 (06): : 772 - 772
  • [30] ANALYSIS OF THE INHIBITORY EFFECTS OF VP-16-213 (ETOPOSIDE) AND PODOPHYLLOTOXIN ON THYMIDINE TRANSPORT AND METABOLISM IN EHRLICH ASCITES TUMOR-CELLS INVITRO
    YALOWICH, JC
    GOLDMAN, ID
    [J]. CANCER RESEARCH, 1984, 44 (03) : 984 - 989
12345